Meeting Report: The 2009 San Antonio Breast Cancer Symposium
Understanding the role of antiangiogenesis therapies in metastatic disease and optimizing treatment of patients with HER2-positive disease were common themes.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)